Testing effectiveness (Phase 2)Study completedNCT00410189What this trial is testingBATTLE Program: ZD6474 in Previously Treated Subjects With NSCLCWho this might be right forLung Cancer M.D. Anderson Cancer Center 54
Not applicableStudy completedNCT05406089What this trial is testingEffects of Antiviral Therapy on Patients With HBV-related HCCWho this might be right forHepatocellular CarcinomaHepatitis B VirusSurvival First Affiliated Hospital Xi'an Jiaotong University 494
Not applicableLooking for participantsNCT07224750What this trial is testingA Noninvasive and Screening miRNA Signature for Gastrointestinal CancerWho this might be right forHepatocellular Carcinoma (HCC)CholangiocarcinomaPancreatic Ductal Adenocarcinoma (PDAC)+3 more City of Hope Medical Center 1,000
Early research (Phase 1)UnknownNCT02457650What this trial is testingT Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing MalignanciesWho this might be right forBladder CarcinomaBreast CancerEsophagus Carcinoma+7 more Shenzhen Second People's Hospital 36
Testing effectiveness (Phase 2)Looking for participantsNCT04585750What this trial is testingThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)Who this might be right forAdvanced Solid TumorAdvanced Malignant NeoplasmMetastatic Cancer+27 more PMV Pharmaceuticals, Inc 300
Early research (Phase 1)Ended earlyNCT05573035What this trial is testingInvestigate LYL845 in Adults With Solid TumorsWho this might be right forMelanomaNon-small Cell Lung CancerColorectal Cancer Lyell Immunopharma, Inc. 39
Testing effectiveness (Phase 2)Looking for participantsNCT06582940What this trial is testingElimination of PTV Margins Based on MRI-guided Adaptive Stereotactic Radiotherapy for Non-small Cell Lung Cancer With Brain MetastasisWho this might be right forMRI-guided Adaptive RadiotherapyNon-small Cell Lung CancerBrain Metastasis Sun Yat-sen University 168
Testing effectiveness (Phase 2)Study completedNCT04548440What this trial is testingEfficacy and Safety of Preoperative Sintilimab Plus Nab-paclitaxel and Cisplatin in BR-ESCC PatientsWho this might be right forEsophageal Squamous Cell Carcinoma Sun Yat-Sen University Cancer Center 50
Not applicableUnknownNCT04528940What this trial is testingTumor Grade Determines PD-1/PDL-1 ExpressionWho this might be right forEndometrial CancerOvarian Cancer RWJ Barnabas Health at Jersey City Medical Center 100
Large-scale testing (Phase 3)Ended earlyNCT00412217What this trial is testingErlotinib (Tarceva) in Participants With Resected Head and Neck Squamous Cell CancerWho this might be right forHead and Neck Cancer Hoffmann-La Roche 94
Not applicableEnded earlyNCT01077440What this trial is testingPresence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell TransplantWho this might be right forCancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more Vanderbilt University 24
Testing effectiveness (Phase 2)Study completedNCT06087289What this trial is testingEvaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forEpithelial Ovarian CancerFallopian Tube CancerPeritoneal Cancer Novakand Pharma AB 18
Not applicableLooking for participantsNCT06991868What this trial is testingProspective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)Who this might be right forNMIBCMIBCUTUC Peking University First Hospital 300
Not applicableLooking for participantsNCT06728891What this trial is testingAnalysis of Tumor Deposit at the Fusion Site of the Right Gastric Mesentery and Left Gastric Mesentery in the Patients With Gastric Cancer Who Received Proximal GastrectomyWho this might be right forGastric Carcinoma Jichao Qin 100
Early research (Phase 1)Active Not RecruitingNCT06049576What this trial is testingNivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell CarcinomaWho this might be right forClear Cell Renal Cell CarcinomaSarcomatoid Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more City of Hope Medical Center 31
Not applicableNot Yet RecruitingNCT07786376What this trial is testingAI in Histipathological Diagnosis of BccWho this might be right forBasal Cell Cancer Al-Azhar University 50
Very early researchEnded earlyNCT04150874What this trial is testingContrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAEWho this might be right forHepatocellular CarcinomaLiver Cancer H. Lee Moffitt Cancer Center and Research Institute 4
Testing effectiveness (Phase 2)UnknownNCT05775874What this trial is testingEvaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUCWho this might be right forUrothelial Carcinoma Abbisko Therapeutics Co, Ltd 80
Early research (Phase 1)Looking for participantsNCT06885697What this trial is testingAnti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including MesotheliomaWho this might be right forMesotheliomaNeoplasmsStomach Neoplasms+5 more National Cancer Institute (NCI) 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04666090What this trial is testingCarrelizumab, Chemotherapy and Apatinib in the Neoadjuvant Treatment of Resectable Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell CarcinomaNeoadjuvant Therapy Second Affiliated Hospital, Zhejiang University, School of Medicine 42